Blockchain Registration Transaction Record

PX1 Research Expands cGMP Quality Control with HPLC Purity Verification

PX1 Research expands cGMP quality control with HPLC purity verification, ensuring 99%+ purity for research peptides like Tirzepatide and BPC-157, with batch-specific COAs.

This news is significant for researchers and academic institutions that rely on high-purity peptides for non-clinical studies. By implementing rigorous cGMP quality control and HPLC purity verification with batch-specific Certificates of Analysis, PX1 Research addresses critical concerns about transparency and reliability in the research supply chain. This move sets a higher standard for domestic peptide manufacturing, ensuring that scientists can trust the integrity and consistency of their research materials, which is essential for reproducible and credible scientific outcomes. It also highlights the importance of sourcing from suppliers that prioritize quality and regulatory compliance, ultimately advancing scientific progress and maintaining the integrity of research data.